🟠 Moderate Evidence
Vitamin D insufficiency is reaching epidemic proportions in temperate and northern climates, with prevalence estimates ranging from 40% in the United States to as high as 97% in some Canadian populations, according to peer-reviewed epidemiological data. The deficiency disproportionately affects individuals living at higher latitudes and those with darker skin tones, who face biological barriers to vitamin D synthesis that can require five to ten times greater sun exposure than lighter-skinned individuals to achieve comparable levels.
Key takeaways
- Vitamin D insufficiency affects 40% of Americans and up to 97% of Canadians, with prevalence increasing northward
- People living at 40 degrees north or south of the equator receive virtually no biogenic vitamin D synthesis during winter months
- Darker-skinned individuals require 5–10 times more sun exposure than lighter-skinned individuals to produce equivalent active vitamin D levels due to melanin’s UVB absorption
- Metabolic bone disease (rickets and osteoporosis) represent the most clinically visible impacts of prolonged deficiency
Vitamin D Insufficiency Prevalence by Geography and Population
Estimated percentage of populations living in vitamin D insufficiency, North America
Source: Epidemiological surveys cited in peer-reviewed literature | Georgian Medical Journal News
Latitude as a Critical Risk Factor
Geographic location fundamentally determines vitamin D synthesis capacity. According to established dermatological and endocrinological research, individuals living north of 40 degrees latitude receive insufficient ultraviolet B (UVB) radiation during winter months to support biogenic vitamin D production, creating a seasonal insufficiency that can persist for months in northern regions. This phenomenon explains the steep gradient in vitamin D prevalence between equatorial and temperate climates.
The mechanism is photochemical: UVB wavelengths (290–320 nm) are required to convert 7-dehydrocholesterol in skin to pre-vitamin D, which then undergoes thermal isomerization and hepatic hydroxylation to form calcidiol (25-hydroxyvitamin D), the marker used clinically to assess vitamin D status. At higher latitudes, the sun’s angle in winter reduces UVB penetration through the atmosphere, making adequate outdoor exposure impractical during the coldest months. This creates a predictable winter insufficiency that can be mitigated through dietary sources or supplementation but often is not, leaving many northern populations chronically deficient.
Melanin and Skin Tone: Biological Barriers to Synthesis
A critical but often overlooked factor in vitamin D deficiency epidemiology is the protective effect of skin pigmentation. According to dermatological research, the epidermal pigment melanin efficiently absorbs incident UVB radiation, reducing the quantum yield of vitamin D synthesis in the skin. Individuals with skin types V and VI (darker tones, which seldom burn and always tan) require between 5 and 10 times greater UVB exposure than individuals with skin types I and II (light tones, which burn easily and rarely or never tan) to produce equivalent circulating levels of calcidiol.
This difference has an evolutionary basis: lighter skin evolved as an adaptation in populations that migrated to higher latitudes with lower ambient UVB, allowing efficient vitamin D synthesis. Darker skin, conversely, evolved in equatorial and tropical regions with intense year-round UVB radiation, where melanin protection against carcinogenesis provided a survival advantage. When darker-skinned populations migrate to temperate climates, this evolutionary adaptation becomes a physiological liability, placing them at substantially elevated risk for vitamin D insufficiency and its sequelae—particularly relevant in temperate-zone diaspora populations across North America and Northern Europe.
Darker-skinned individuals require 5–10 times greater sun exposure than lighter-skinned individuals to achieve the same circulating vitamin D levels, a difference rooted in melanin’s UVB absorption efficiency.
— Peer-reviewed dermatological and endocrinological literature
Clinical Consequences: Bone Health and Beyond
The most clinically visible impact of prolonged vitamin D deficiency is metabolic bone disease. The spectrum ranges from rickets (primarily type I, reflecting renal dysfunction or genetic defects in vitamin D metabolism) in children to osteoporosis in adults. Vitamin D insufficiency impairs intestinal calcium absorption and increases parathyroid hormone (PTH) secretion, triggering secondary hyperparathyroidism, which drives osteoclastic bone resorption and progressive loss of bone mineral density.
Beyond the skeletal system, emerging evidence links vitamin D deficiency to neuromuscular dysfunction, immune dysregulation, and cardiovascular disease, though these associations require further mechanistic clarification. The neuromuscular and skeletal systems remain the most robustly established targets of vitamin D insufficiency, making screening and supplementation particularly important in high-risk populations: those at higher latitudes, individuals with darker skin living in temperate regions, and those with limited sun exposure due to occupational or lifestyle factors.
What this means
Vitamin D Testing and Population Screening
Clinical vitamin D status is assessed by measuring serum 25-hydroxyvitamin D (calcidiol), the major circulating form. Most guidelines define insufficiency as levels below 30 ng/mL and deficiency as below 20 ng/mL, though optimal levels remain debated. Given the high prevalence in temperate and northern populations—reaching 40% in the United States and 70–97% in Canada—systematic screening in primary care may be justified, particularly in high-risk subgroups. However, clinical updates on screening recommendations vary between organizations, and cost-effectiveness analyses remain mixed.
Supplementation strategies range from dietary fortification (milk, cereals, fish oils) to pharmacological supplementation. Vitamin D3 (cholecalciferol, derived from animal sources or lichen) is generally considered more potent than vitamin D2 (ergocalciferol, derived from fungi), though both are widely available and effective. Typical supplementation doses range from 400–2000 IU daily for maintenance to higher doses (up to 50,000 IU weekly) for correction of deficiency, depending on baseline status and individual needs. Toxicity from supplementation is rare but can occur at doses exceeding 10,000 IU daily chronically; monitoring is recommended in at-risk populations.
Frequently asked questions
Why do darker-skinned individuals have lower vitamin D levels?
Melanin, the pigment that gives darker skin its color, efficiently absorbs ultraviolet B (UVB) radiation from the sun. This protection against sun damage reduces the amount of UVB that reaches the deeper skin layers where vitamin D is synthesized. As a result, darker-skinned individuals require significantly more sun exposure—up to 5–10 times longer—to produce the same amount of vitamin D as lighter-skinned individuals. This is an evolutionary adaptation that protected against skin cancer in equatorial regions but creates a disadvantage in temperate climates with limited winter UVB.
Can I get enough vitamin D from food alone in a northern climate?
Food sources of vitamin D include fatty fish (salmon, mackerel, herring), fortified milk and plant-based alternatives, egg yolks, and mushrooms exposed to sunlight. However, natural food sources are limited, and the amount of fortification varies by country and product. In northern regions during winter, food alone is typically insufficient to maintain adequate vitamin D levels; supplementation is usually necessary. Discuss your individual needs with your clinician, who can recommend appropriate doses based on your age, skin tone, dietary intake, and sun exposure.
What is the difference between vitamin D insufficiency and deficiency?
Serum 25-hydroxyvitamin D concentration defines status: deficiency is typically defined as below 20 ng/mL and is associated with increased risk of rickets and metabolic bone disease. Insufficiency is defined as 20–29 ng/mL, a state in which bone health may be compromised and some clinical effects may emerge, particularly with additional risk factors. Most experts recommend maintaining levels above 30 ng/mL for optimal bone and immune health, though exact optimal levels remain debated in the medical literature.
As awareness of vitamin D insufficiency grows among both clinicians and the public, integrated strategies combining modest lifestyle changes (increased outdoor time when possible), dietary optimization, and targeted supplementation in high-risk populations offer a practical pathway to reducing the burden of preventable bone disease and supporting broader metabolic health in temperate and northern climates worldwide.
Source: Peer-reviewed epidemiological studies on vitamin D insufficiency prevalence and Clinical Updates
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
